Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gallagher

Showing results (791-800 of 806) with videos related to

Pageof 81
Sort By:
Genome Biology|June 7, 2007
Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strainsLaurence Rohmer, Christine Fong, Simone Abmayr, et al.
European Journal of Human Genetics : EJHG|March 26, 2015
Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in ItalyMartina Nemethova, Jan Radvanszky, Ludevit Kadasi, et al.
Annals of the Rheumatic Diseases|December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatmentLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Science Translational Medicine|June 20, 2020
ctDNA monitoring using patient-specific sequencing and integration of variant readsJonathan C M Wan, Katrin Heider, Davina Gale, et al.
Abdominal Radiology (New York)|December 10, 2025
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-<sup>13</sup> C]pyruvate MRIInes Horvat-Menih, Mary A McLean, Jonathan Birchall, et al.
Cancers|January 21, 2022
Hyperpolarized <sup>13</sup>C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle StudyStephan Ursprung, Ramona Woitek, Mary A McLean, et al.
Magnetic Resonance in Medicine|June 16, 2025
Consensus recommendations for hyperpolarized [1-<sup>13</sup>C]pyruvate MRI multi-center human studiesShonit Punwani, Peder E Z Larson, Christoffer Laustsen, et al.
Cancer Research|October 9, 2021
Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer PatientsRamona Woitek, Mary A McLean, Stephan Ursprung, et al.
Arxiv|May 9, 2025
Consensus Recommendations for Hyperpolarized [1-<sup>13</sup>C]pyruvate MRI Multi-center Human StudiesShonit Punwani, Peder Ez Larson, Christoffer Laustsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2020
Imaging breast cancer using hyperpolarized carbon-13 MRIFerdia A Gallagher, Ramona Woitek, Mary A McLean, et al.
Pageof 81

Showing results (791-800 of 806) with videos related to

Sort By:
Pageof 81
Genome Biology|June 7, 2007
Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strainsLaurence Rohmer, Christine Fong, Simone Abmayr, et al.
European Journal of Human Genetics : EJHG|March 26, 2015
Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in ItalyMartina Nemethova, Jan Radvanszky, Ludevit Kadasi, et al.
Annals of the Rheumatic Diseases|December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatmentLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Science Translational Medicine|June 20, 2020
ctDNA monitoring using patient-specific sequencing and integration of variant readsJonathan C M Wan, Katrin Heider, Davina Gale, et al.
Abdominal Radiology (New York)|December 10, 2025
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-<sup>13</sup> C]pyruvate MRIInes Horvat-Menih, Mary A McLean, Jonathan Birchall, et al.
Cancers|January 21, 2022
Hyperpolarized <sup>13</sup>C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle StudyStephan Ursprung, Ramona Woitek, Mary A McLean, et al.
Magnetic Resonance in Medicine|June 16, 2025
Consensus recommendations for hyperpolarized [1-<sup>13</sup>C]pyruvate MRI multi-center human studiesShonit Punwani, Peder E Z Larson, Christoffer Laustsen, et al.
Cancer Research|October 9, 2021
Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer PatientsRamona Woitek, Mary A McLean, Stephan Ursprung, et al.
Arxiv|May 9, 2025
Consensus Recommendations for Hyperpolarized [1-<sup>13</sup>C]pyruvate MRI Multi-center Human StudiesShonit Punwani, Peder Ez Larson, Christoffer Laustsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2020
Imaging breast cancer using hyperpolarized carbon-13 MRIFerdia A Gallagher, Ramona Woitek, Mary A McLean, et al.
Pageof 81